StocksDeepDive
Snapshot · All Ordinaries · generated 2026-09-19 21:51 UTC

AFP.AX — AFT Pharmaceuticals Limited

EXPENSIVE (MOS -337.0%) · Quality 48/100

Price
3.54
Intrinsic value
0.81
Margin of safety
-337.0%
Implied growth (reverse DCF)
+18.3%
model assumes +0.0%
Value Score
8
Quality
48
Psychology
10.3
Discovery
3.5
price/volume attention only
Moat score
31
erosion: none

Value Score: bottom 7% of All Ordinaries · Quality: bottom 22%

Dividend: 0.0135/share (TTM) · yield 0.4% · payout 12%

Open the interactive Deep Dive for AFP.AX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/AFP.AX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is AFP.AX undervalued?

As of 2026-09-19, AFP.AX trades at 3.54 against a computed intrinsic value of 0.81 (-337.0% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is AFT Pharmaceuticals Limited's Value Score?

AFT Pharmaceuticals Limited's Value Score is 8 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.

Does AFP.AX pay a dividend?

Yes - AFP.AX's trailing twelve-month dividend is 0.0135/share, a yield of 0.4% at the current price (as of 2026-09-19).